A wide variety of compounds was examined for the ability to induce a specific form of hepatic cytochrome P~M and to promote the development of DEN-initiated liver tumors (adenomas and carcinomas) in rats over a 72 week period. The induction of cytochrome P4Mb was determined indirectly by measuring the hepatic induction of pentoxy-or benzyloxyresorufin 0-dealkylase activities, which are highly specific substrates for the major phenobarbital-inducible forms of cytochrome P450 in the rat.("J) Results in the rat showed: (1) potent inducers (> 40 X) of P450b (i.e., phenobarbital, barbital, ethylphenylhydantoin, and DDT) are all potent liver tumor promoters; (2) structural analogs that are not inducers of P450b (i.e., hexobarbital, monoethylbarbituric acid, monophenylbarbituric acid, and diethylhydantoin) all fail to display significant liver tumor promoting activity; and (3) the concomitant induction of liver hypertrophy, microsomal epoxide hydrolase, and cytochrome P450b appears to be proportional and argues for some coordinated "pleiotropic" response of liver parenchyma to these inducers. Additional studies showed that phenobarbital induced cytochrome P450b and was a liver tumor promoter not only in rats, but also in mice and patas monkeys, but was inactive as an enzyme inducer and was a nonpromoter in the hamster.
INTRODUCTION
N THIS PRESENTATION, we briefly review the empirical relationship between induction of I multiple enzyme activities [cytochrome(s) P450 and epoxide hydrolase] and tumor promotion in the liver. We then discuss a possible role of some putative receptor in mediating these effects. The specific points include: This project has been funded at least in part with federal funds from the Department of Health and Human Services under contract number N01-CO-74102. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. 
The correlation between induction of cytochrome

DEALKYLATION OF PENTOXY OR BENZYLOXY PHENOXAZONES
The cytochromes P450 are a family of hemoproteins associated with microsomal membranes. Together with NADPH cytochrome P450 reductase and reducing equivalents, these enzymes mediate the primary (phase I) oxidative metabolism of steroids. fatty acids, prostaglandins, leukotrienes, pheromones, and a vast number of xenobiotics.(l,?) Certain members of this family are readily inducible by a variety of substances, and specific patterns of association exist between individual cytochrome P450 isozymes and the limited spectrum of compounds that can induce synthesis of a given isozyme. Furthermore, compounds that serve as inducers of specific cytochrome P450 isozymes generally (but not always) serve as substrates for it.
The metabolism and thereby the biologic efficacies of many compounds depend on the various specific forms of cytochrome P450 present in the liver. Thus, assays that either directly (i.e., immunoquantitation)(3.4, or indirectly (i.e., enzymatic assays) measure the major types and degree of induction of these various forms of cytochrome P450 have gained considerable importance. Previous work by Burke, Mayer, and others has demonstrated that the de-ethylation of ethoxyresorufin is highly specific for 3-methylcholanthrene (3MC)-inducible forms of cytochrome P450 in a wide variety of species and tissues.(5.6) In contrast, the substrates (aminopyrine and ethylmorphine) routinely employed to quantify the major forms of cytochrome P450 induced by phenobarbital (PB)-like compounds exhibit little specificity. Recently, work both by ourselves and by Burke and collaborators~7-~0) has demonstrated that the 0-dealkylation of the two phenoxazone ethers, pentoxy-and benzyloxyresorufin, appears to be specifically mediated by the primary PB-inducible form of cytochrome P450 (P450b) (Table 1) in the rat. Further studies employing specific chemical inhibitors and polyclonal antibodiescs-10) have confirmed these results and confirm that these reactions are highly sensitive and specific assays for quantifying PB-type induction in a wide variety of species, including the mouse,(7) rat, rabbit (R.M. Philpot, personal communication), and monkey (R.A. Lubet et al., unpublished observations).
CORRELATION BETWEEN INDUCTION OF "PB-TYPE" CYTOCHROMES P450AND PROMOTION OF DEN-INITIATED LIVER TUMORS IN RATS
The induction of mixed-function oxidase activities by structurally diverse classes of liver tumor promoters, including barbiturates, chlorinated hydrocarbon pesticides, polyhalogenated biphenyls, hypolipidemic peroxisome proliferating agents, and certain steroids, has been previously reviewed.(lJJ 1 ) Possible correlations between the abilities of a compound to induce cytochrome P450 and to promote carcinogenesis have been suggested by a number of investigators.(l*-14) Employing the newly developed dealkylation assays, we first examined the relationship between P450 induction and liver tumor promoting activity, based on various studies in the literature, for a series of barbiturates.@) We have more recently expanded this to include additional barbiturates, hydantoins, and certain chlorinated pesticides (Table 2 ). Alkoxyresorufin 0-dealkylase activities were determined in 9000 X g supernatants as previously described. (9,lo) To examine the relationship of P450 induction to liver tumor promotion, these barbiturates and hydantoins were assayed for promotion of DEN-initiated hepatocarcinogenesis.(IsJ6) Methods for determining a promotion index from these data are given in Table 3 . As can readily be seen, there are striking differences between promotability by the various barbiturate and mean f standard deviation for ti = 5 rats per treatment.
hydantoin analogs (Fig. 1) . Thus, PB and ethylphenylhydantoin were strong promoters, barbital was intermediate. and diethylhydantoin, 5-ethylbarbituric acid, 5-phenylbarbituric acid, and barbituric acid were negligibly active. When these compounds were ranked according to liver tumor promoting activity and t o ability to induce "PB-type" cytochrome P450, a strong correlation was observed (r = 90.8%).
Those compounds that were strong inducers are strong promoters, and vice versa. In interpreting these results one must be aware that (1) we have examined a series of analogs of clinically important but structurally related drugs, and (2) we have looked at specific form(s) of cytochrome P450 (those typically induced by PB) that may not be inducible by other classes of liver tumor promoters, many of which (e.g., clofibrate and TCDD) may induce other forms of cytochrome P450.".') aBarbiturates were administered in the drinking water (500 ppm) for 52-78 weeks following initiation with DEN (one IP injection; 75 mg/kg body weight). bIncidence = the percentage of animals at risk that bear tumors of the specified type (in parentheses, the number of tumor-bearing animals per number of animals at CMultiplicity = the number of specified tumors occurring in animals bearing the specified tumor type.
dCombined tumor incidence (CTI) = (carcinoma incidence X carcinoma multiplicity)
+ (adenorna incidence X adenoma multiplicity).
CRelative promotion index = (CTI)Unknown/(CTI)phenobarbital.
risk). 
CORRELATION BETWEEN THE INDUCTION OF CYTOCHROME P4oa AND EPOXIDE HYDROLASE
Microsomal epoxide hydrolase (EC 3.3.2.3) is an enzyme found in a variety of mammalian tissues that hydrates alkyl epoxides and arene oxides to vicinal trans-diols.cl7) Interestingly, this enzyme has been observed at high levels in preneoplastic liver foci and in hepatocellular tumors preceding overt hepatocellular carcinoma in rats.cl8) Because of its prevalence in premalignant lesions, some workers have hypothesized that chemicals that promote liver neoplasia are likely to induce epoxide hydrolase.(lg' Our own investigations with epoxide hydrolase were undertaken to examine its potential "coordinate" induction by compounds that induce cytochrome P450b (Table 1 ). This expectation was based in large part on the observation that strong inducers of cytochrome P450b (e.g., PB and DDT) were strong inducers of epoxide hydrolase.@O) The results shown in Figure 2 demonstrate that there is a close correlation between the induction of cytochrome P450b and epoxide hydrolase ( r = 94.6%). Epoxide hydrolase activity was determined by measuring the hydration of benzo[a]pyrene-4,5-oxide to the corresponding 4,5-diol in 9000 X g supernatants as previously described. 
EPOXIDE HYDROLASE (NMOL/MIN/MG)
FIG. 2.
Correlation between induction of benzyloxyresorufin 0-dealkylase activity (cytochrome P45Ob) and epoxide hydrolase activity by various chemicals administered in the diet for a period of 14 days at the indicated doses to 6-to 8-week-old male F344 rats. Enzyme activities were measured in liver 9000 g supernatants. Abbreviations and dosages used: barbital sodium (BB, 500 ppm); control diet (CTL); dichlorodiphenyltrichloroethane (DDT, 500 ppm); diethylhydantoin (EEH, 336 ppm); ethylphenylhydantoin (EPH, 440 ppm); a-hexachlorocyclohexane (LIN, 320 pprn); phenobarbital (PB, 500 pprn); diphenylhydantoin (PPH, 500 pprn); valproic acid (VAL, 500 ppm). Correlation statistic r = 94.6%.
T h e w reciiltq nlthniluh nnt nrnnf cpem m n c t rnmnatihle with the hvnnthecic that rnmnniinds hydrolase. The converse is not true since some strong inducers of microsomal epoxide hydrolase appear to have limited effects on cytochrome P450b.'19' Whether this apparent "coordinate" induction is mediated by (1) some common receptor mechanism, (2) secondary increases in epoxide hydrolase in response to direct cytochrome P450b induction, or (3) some common biochemical path not necessarily involving a receptor. is not known. Attempts to define a highaffinity saturable "receptor" for PB-type inducers have not been successful (e.g., Ref. 21) . This is in contrast to demonstrated receptors for methylcholanthrene-TCDD and hypolipidemic drugs.@)
RELATIONSHIP BETWEEN INDUCTION OF CYTOCHROME P450b AND TUMOR PROMOTION IN VARIOUS ANIMAL SPECIES
Most of the work to date examining liver tumor promotion has been performed in either the rat or the mouse. In fact, a variety of models of liver tumor promotion have been developed in the rat to study questions related to induction, promotion, selection, and so on (see review, Ref. standard deviation (number of animals given in parentheses). 22 ). In view of the good correlation between induction of cytochrome P450h and promotion in the rat, we extended this correlation to three other species, the mouse, the Syrian golden hamster, and the patas monkey. The rationale for studying hamsters was that previous data from two laboratories demonstrated that this species is not susceptible to liver tumor promotion by PB.(l3.24) Promotion protocols in our laboratory have involved tumor initiation by DEN (single injection in rodents and multiple injections in monkeys) followed by continuous administration of PB in the diet or drinking water (Table 4) . Both mice and rats exhibited strong cytochrome P450 induction by PB and demonstrated susceptibility to liver tumor promotion. Hamsters exhibited minimal cytochrome P450 induction and appeared to be resistant to liver tumor promotion: the African primate (Erythrocebus patas) exhibited strong cytochrome P450 induction by PB and a strong liver tumor promotion response.(?5) These data are consistent with the general hypothesis that induction of PB-inducible isozymes of cytochrome P450 is apparently associated with liver tumor promotion in a variety of species, both rodent and nonrodent.
TUMOR-PROMOTING ACTIVITY OF BARBITURATES AND HYDANTOINS IN EXTRAHEPATIC TISSUES
In addition to their ability to promote liver tumorigenesis, at least some of these compounds can promote tumorigenesis in other organs as well (Table 5) . Phenobarbital, barbital, and ethylphenylhydantoin all enhance the development of thyroid follicular adenomas and carcinomas following DEN initiation. It has been postulated that these effects may be due to alterations in thyroid hormone levels following induction of hepatic P450s. Barbital, but interestingly not phenobarbital, also enhances kidney tumor development.(l3) This may be due to a hydrolysis product and metabolite of barbital, diethylacetylurea, which we have recently found to promote kidney tumor formation but which lacks any effect on hepatocarcinogenesis. (26) Barbital causes substantial cell division in the kidney and may function in part via this mitogenic function. Several investigators have also demonstrated mitogenic effects of "most PBtype inducers" on hepatocytes from rats that had not been exposed to any carcinogen,(z7) but this bIncidence: number of rats with tumodnumber of exposed rats.
CSignificantly different from the group treated with DEN alone, p I 0.05 (chi-square test).
stimulus is very slight (labeling index < 0.8%). This argues that the primary promoting effect of PB in the liver is unlikely to be mitogenicity. However, elegant work by Shulte-Hermann and coworkers argues strongly that PB and some of the other liver tumor promoters preferentially induce cell division in initiated (preneoplastic) cells.(*7)
SUMMARY
In summary, we have shown:
1. Quantitative 0-dealkylation of benzyloxy-or pentoxyresorufin can be used as a sensitive indirect measure of the major PB-inducible forms of cytochrome P450 in various species. 2. There is a strong correlation in the rat between induction of cytochrome P450b and liver tumor promoting activity by a variety of chemicals. 3. There is evidence for coordinate induction of PB-specific cytochromes and epoxide hydrolase. This result could be explained by a receptor-type mechanism, but is no proof thereof.
4.
There is a strong correlation between phenobarbital induction of pentoxyresorufin 0-dealkylase and liver tumor promoting activity in both rodent and nonrodent species.
5. PB and similar inducers appear to promote thyroid follicular cell neoplasia.
